Beth Calitri

VP, Corporate Communications

Beth is a dynamic communications leader with a proven track record of shaping narratives that drive impact across the biotech, pharmaceutical, and agency landscapes. She has held senior roles at industry leaders including Pfizer, Novartis, and AstraZeneca, worked at agile biotech innovators, and advised top-tier healthcare clients during her time at global communications firms such as Ogilvy.

At MindMed, Beth brings her strategic vision, scientific fluency, and cross-sector expertise to elevate the company’s reputation, visibility, and growth trajectory. Her communications expertise runs deep in neuroscience, where she has led domestic and global strategies across therapeutic areas including Alzheimer’s disease, epilepsy, schizophrenia, attention-deficit/hyperactivity disorder, Parkinson’s disease, major depressive disorder, and multiple sclerosis. This specialization brings a unique edge to her work, enabling her to lead with empathy, credibility, and precision in some of the most scientifically complex and socially stigmatized areas of medicine. Beth’s approach is grounded in authenticity, inclusivity, and trust. Whether she’s crafting compelling scientific narratives, navigating high-impact issues, or executing integrated media campaigns, she brings clarity and resonance to even the most complex topics. She’s passionate about building transparent, purpose-driven cultures that align teams and engage stakeholders.

International in both background and experience, Beth is a two-time expatriate, having completed assignments in the UK and Basel, Switzerland. Her global exposure informs her collaborative leadership style and her ability to connect across cultures and markets. She has received numerous industry awards and serves on the Executive Advisory Board of the University of Rhode Island’s Harrington School of Communication and Media, where she mentors emerging communications talent. Beyond her professional work, Beth is a committed advocate for causes close to her heart, frequently lending her voice, time, and expertise to initiatives that reflect her values.

Paul Summergrad, MD

Professor of Psychiatry and Medicine at Tufts University School of Medicine and Chairman Emeritus of the department of psychiatry at Tufts Medical Center

Nzinga Harrison, MD

Co-Founder & Chief Medical Officer, Eleanor Health

Carol Vallone

Chair of the Board of Directors, Member of Compensation Committee, Member of Audit Committee

Andreas Krebs

Vice Chair of the Board of Directors, Member of Nomination & Governance Committee, Member of Audit Committee

David Gryska

Board Director, Chair of Audit Committee

Roger Crystal, MD

Board Director, Chair of Nomination & Governance Committee, Member of Compensation Committee

Robert Barrow

Chief Executive Officer and Board Director

Suzanne Bruhn, PhD

Board Director, Chair of Compensation Committee, Member of Nomination & Governance Committee

Daniel Karlin, MD, MA

Chief Medical Officer

Stephanie Fagan, MS

Chief Corporate Affairs Officer

Carrie Liao, CPA

Chief Accounting Officer

Gregg Pratt, PhD

Chief Regulatory and Quality Assurance Officer

Mark Sullivan, JD

Chief Legal Officer and Corporate Secretary

Matt Wiley

Chief Commercial Officer

Robert Malenka, MD, PhD

Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University

Peter Bergethon, MD

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.

Robert Dworkin, PhD

Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester

Maurizio Fava, MD

Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)

Peter Mack, PhD

SVP, Pharmaceutical Development and Operations

Beth Calitri

VP, Corporate Communications

Phong Duong, PharmD

VP, Market Access and Health Economics

Julie Garner

VP, Government Affairs and Patient Advocacy

Javier Muniz, MD

VP, Research and Development Strategy

Lysa Triantafillou

VP, Quality Assurance

Maria Oquendo, MD, PhD

Ruth Meltzer Professor and Chairman of Psychiatry at University of Pennsylvania, Psychiatrist-in-Chief at the Hospital of the University of Pennsylvania

Matthias Liechti, MD, PhD

Scientific Collaborator & Advisor

Kim PC Kuypers, PhD

Scientific Collaborator & Advisor

Peter Gasser, MD

Clinical Advisor
×

Thanks for visiting!

You are leaving MindMed and will be automatically redirected to ${url} in a moment.

Change your mind?

Return to Mindmed